Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

During the Trading Day
26.81 +0.73 / +2.80%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
26.82 +0.0054 / +0.02%
 
Volume: 2.4K

Today’s Trading

Previous close26.08
Today’s open26.47
Day’s range25.83 - 26.99
Volume980,919
Average volume (3 months)1,881,130
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)+135.58%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+190.87%
P/E ratio26.1
Price/Sales2.74
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
DNAIProNAi Therapeutics ...+1.69+5.86%
VBLTVascular Biogenics L...+0.08+1.50%
NEPTNeptune Technologies...-0.03-2.32%
TEVATeva Pharmaceutical+1.66+2.63%
Data as of 4:02pm ET, 09/02/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.20
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers